EUVIMEDEUVIMED entdecken
Crossref

Pharmacological Inhibition or Silencing of TREM1 Restrains HCC Cell Metastasis by Inactivating TLR/PI3K/AKT Signaling

Ling Ren, Guang-Lei Qiao, Shu-Xian Zhang, Zhi-Mei Zhang, Sheng-Xiang Lv

Cell Biochemistry and Biophysics · 2024

DOI: 10.1007/s12013-024-01377-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2024. Verfasst von Ling Ren und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Affifiliated Lianyungang Hospital of Xuzhou Medical University, The First People's Hospital of Lianyungang, Liany…. Hauptthemen laut MEDLINE: Triggering Receptor Expressed on Myeloid Cells-1, Liver Neoplasms, Carcinoma, Hepatocellular, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Lianyungang High-Tech Zone Science and Technology Project, Shanghai Tongren Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC), a widely prevalent malignancy strongly linked to inflammation, remains a significant public health concern. Triggering receptor expressed on myeloid cells 1 (TREM1), a modulator of inflammatory responses identified in recent years, has emerged as a crucial facilitator in cancer progression. Despite its significance, the precise regulatory mechanism of TREM1 in HCC metastasis remains unanswered. In the present investigation, we observed aberrant upregulation of TREM1 in HCC tissues, which was significantly linked to poorer overall survival. Inhibition of TREM1 expression resulted in a significant reduction in HCC Huh-7 and MHCC-97H cell proliferation, invasion, and epithelial-mesenchymal transition (EMT) process. Furthermore, inhibiting TREM1 decreased protein expressions of toll-like receptor 2/4 (TLR2/4) and major myeloid differentiation response gene 88 (MyD88), leading to the inactivation of phosphatidylinositol 3-kinase (PI3K) and protein kinase B (AKT) in HCC cells. Notably, these effects were reversed by treatment with TLR2-specific agonist (CU-T12-9), indicating a potential crosstalk between TREM1 and TLR2/4. Mechanistic studies revealed a direct interaction between TREM1 and both TLR2 and TLR4. In vivo studies demonstrated that inhibition of TREM1 suppressed the growth of HCC cells in the orthotopic implant model and its metastatic potential in the experimental lung metastasis model. Overall, our findings underscore the role of TREM1 inhibition in regulating EMT and metastasis of HCC cells by inactivating the TLR/PI3K/AKT signaling pathway, thereby providing deeper mechanistic insights into how TREM1 regulates metastasis during HCC progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triggering Receptor Expressed on Myeloid Cells-1Liver NeoplasmsCarcinoma, HepatocellularProto-Oncogene Proteins c-aktSignal TransductionEpithelial-Mesenchymal TransitionPhosphatidylinositol 3-KinasesHumansCell Line, TumorAnimalsMiceCell ProliferationToll-Like Receptor 4Myeloid Differentiation Factor 88Toll-Like Receptor 2MaleMice, NudeReceptors, ImmunologicMice, Inbred BALB C

Stichwörter der Autor:innen

EMTHepatocellular carcinomaMetastasisTLRTREM1

Substanzen

Triggering Receptor Expressed on Myeloid Cells-1Proto-Oncogene Proteins c-aktTREM1 protein, humanPhosphatidylinositol 3-KinasesToll-Like Receptor 4Myeloid Differentiation Factor 88Toll-Like Receptor 2Receptors, Immunologic

Autor:innen und Institutionen

  • Department of Gastroenterology, The Affifiliated Lianyungang Hospital of Xuzhou Medical University, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, China.
  • Department of Gastroenterology, The Affiliated Hospital of Kangda College of Nanjing Medical University, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, China.
  • Department of Oncology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Gastroenterology, The Affifiliated Lianyungang Hospital of Xuzhou Medical University, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, China. lvshengxiang168@163.com.
  • Department of Gastroenterology, The Affiliated Hospital of Kangda College of Nanjing Medical University, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu, China. lvshengxiang168@163.com.

Förderung

  • Lianyungang High-Tech Zone Science and Technology Project
  • Shanghai Tongren Hospital

Zitieren

APA

Ren, L., Qiao, G. L., Zhang, S. X., Zhang, Z. M., & Lv, S. X. (2024). Pharmacological Inhibition or Silencing of TREM1 Restrains HCC Cell Metastasis by Inactivating TLR/PI3K/AKT Signaling. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01377-8

Vancouver

Ren L, Qiao GL, Zhang SX, Zhang ZM, Lv SX. Pharmacological Inhibition or Silencing of TREM1 Restrains HCC Cell Metastasis by Inactivating TLR/PI3K/AKT Signaling. Cell Biochemistry and Biophysics. 2024. doi:10.1007/s12013-024-01377-8

BibTeX
@article{Ren2024,
  author = {Ren, Ling and Qiao, Guang-Lei and Zhang, Shu-Xian and Zhang, Zhi-Mei and Lv, Sheng-Xiang},
  title = {Pharmacological Inhibition or Silencing of TREM1 Restrains HCC Cell Metastasis by Inactivating TLR/PI3K/AKT Signaling},
  journal = {Cell Biochemistry and Biophysics},
  year = {2024},
  doi = {10.1007/s12013-024-01377-8}
}
Kostenlos starten →